Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Dysbiosis of the gut microbiota and colorectal cancer: the key target of molecular pathological epidemiology.

Literature DB >> 30345420

Dysbiosis of the gut microbiota and colorectal cancer: the key target of molecular pathological epidemiology.

Keisuke Kosumi^1,2, Kosuke Mima^1,2, Hideo Baba², Shuji Ogino^1,3,4,5.

Abstract

Entities: Chemical Disease Species

Year: 2018 PMID： 30345420 PMCID： PMC6195365 DOI： 10.21037/jlpm.2018.09.05

Source DB: PubMed Journal: J Lab Precis Med ISSN： 2519-9005

× No keyword cloud information.

25 in total

1. Leveraging sequence-based faecal microbial community survey data to identify a composite biomarker for colorectal cancer.

Authors: Manasi S Shah; Todd Z DeSantis; Thomas Weinmaier; Paul J McMurdie; Julia L Cope; Adam Altrichter; Jose-Miguel Yamal; Emily B Hollister
Journal: Gut Date: 2017-03-24 Impact factor: 23.059

Review 2. Gut Microbiota, Inflammation, and Colorectal Cancer.

Authors: Caitlin A Brennan; Wendy S Garrett
Journal: Annu Rev Microbiol Date: 2016-09-08 Impact factor: 15.500

3. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment.

Authors: Aleksandar D Kostic; Eunyoung Chun; Lauren Robertson; Jonathan N Glickman; Carey Ann Gallini; Monia Michaud; Thomas E Clancy; Daniel C Chung; Paul Lochhead; Georgina L Hold; Emad M El-Omar; Dean Brenner; Charles S Fuchs; Matthew Meyerson; Wendy S Garrett
Journal: Cell Host Microbe Date: 2013-08-14 Impact factor: 21.023

4. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients.

Authors: V Gopalakrishnan; C N Spencer; L Nezi; A Reuben; M C Andrews; T V Karpinets; P A Prieto; D Vicente; K Hoffman; S C Wei; A P Cogdill; L Zhao; C W Hudgens; D S Hutchinson; T Manzo; M Petaccia de Macedo; T Cotechini; T Kumar; W S Chen; S M Reddy; R Szczepaniak Sloane; J Galloway-Pena; H Jiang; P L Chen; E J Shpall; K Rezvani; A M Alousi; R F Chemaly; S Shelburne; L M Vence; P C Okhuysen; V B Jensen; A G Swennes; F McAllister; E Marcelo Riquelme Sanchez; Y Zhang; E Le Chatelier; L Zitvogel; N Pons; J L Austin-Breneman; L E Haydu; E M Burton; J M Gardner; E Sirmans; J Hu; A J Lazar; T Tsujikawa; A Diab; H Tawbi; I C Glitza; W J Hwu; S P Patel; S E Woodman; R N Amaria; M A Davies; J E Gershenwald; P Hwu; J E Lee; J Zhang; L M Coussens; Z A Cooper; P A Futreal; C R Daniel; N J Ajami; J F Petrosino; M T Tetzlaff; P Sharma; J P Allison; R R Jenq; J A Wargo
Journal: Science Date: 2017-11-02 Impact factor: 47.728

5. A Simple and Novel Fecal Biomarker for Colorectal Cancer: Ratio of Fusobacterium Nucleatum to Probiotics Populations, Based on Their Antagonistic Effect.

Authors: Songhe Guo; Linfang Li; Banglao Xu; Manghui Li; Qiuyao Zeng; Han Xiao; Ying Xue; Yixian Wu; Yidan Wang; Wanli Liu; Ge Zhang
Journal: Clin Chem Date: 2018-06-18 Impact factor: 8.327

Review 6. Action and function of Faecalibacterium prausnitzii in health and disease.

Authors: Carmen Veríssima Ferreira-Halder; Alessandra Valéria de Sousa Faria; Sheila Siqueira Andrade
Journal: Best Pract Res Clin Gastroenterol Date: 2017-09-18 Impact factor: 3.043

Review 7. The role of intestinal bacteria in the development and progression of gastrointestinal tract neoplasms.

Authors: Kosuke Mima; Shuji Ogino; Shigeki Nakagawa; Hiroshi Sawayama; Koichi Kinoshita; Ryuichi Krashima; Takatsugu Ishimoto; Katsunori Imai; Masaaki Iwatsuki; Daisuke Hashimoto; Yoshifumi Baba; Yasuo Sakamoto; Yo-Ichi Yamashita; Naoya Yoshida; Akira Chikamoto; Takatoshi Ishiko; Hideo Baba
Journal: Surg Oncol Date: 2017-07-21 Impact factor: 3.279

Review 8. The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy.

Authors: Vancheswaran Gopalakrishnan; Beth A Helmink; Christine N Spencer; Alexandre Reuben; Jennifer A Wargo
Journal: Cancer Cell Date: 2018-04-09 Impact factor: 31.743

9. Association of Dietary Patterns With Risk of Colorectal Cancer Subtypes Classified by Fusobacterium nucleatum in Tumor Tissue.

Authors: Raaj S Mehta; Reiko Nishihara; Yin Cao; Mingyang Song; Kosuke Mima; Zhi Rong Qian; Jonathan A Nowak; Keisuke Kosumi; Tsuyoshi Hamada; Yohei Masugi; Susan Bullman; David A Drew; Aleksandar D Kostic; Teresa T Fung; Wendy S Garrett; Curtis Huttenhower; Kana Wu; Jeffrey A Meyerhardt; Xuehong Zhang; Walter C Willett; Edward L Giovannucci; Charles S Fuchs; Andrew T Chan; Shuji Ogino
Journal: JAMA Oncol Date: 2017-07-01 Impact factor: 31.777

10. Integration of pharmacology, molecular pathology, and population data science to support precision gastrointestinal oncology.

Authors: Shuji Ogino; Iny Jhun; Douglas A Mata; Thing Rinda Soong; Tsuyoshi Hamada; Li Liu; Reiko Nishihara; Marios Giannakis; Yin Cao; JoAnn E Manson; Jonathan A Nowak; Andrew T Chan
Journal: NPJ Precis Oncol Date: 2017-12-06

17 in total

Review 1. The gut microbiome: what every gastroenterologist needs to know.

Authors: Benjamin H Mullish; Mohammed Nabil Quraishi; Jonathan P Segal; Gianluca Ianiro; Tariq H Iqbal
Journal: Frontline Gastroenterol Date: 2020-02-04

Review 2. Integration of microbiology, molecular pathology, and epidemiology: a new paradigm to explore the pathogenesis of microbiome-driven neoplasms.

Authors: Tsuyoshi Hamada; Jonathan A Nowak; Danny A Milner; Mingyang Song; Shuji Ogino
Journal: J Pathol Date: 2019-02-20 Impact factor: 7.996

Dysbiosis of the gut microbiota and colorectal cancer: the key target of molecular pathological epidemiology.

1. Leveraging sequence-based faecal microbial community survey data to identify a composite biomarker for colorectal cancer.

Review 2. Gut Microbiota, Inflammation, and Colorectal Cancer.

3. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment.

4. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients.

5. A Simple and Novel Fecal Biomarker for Colorectal Cancer: Ratio of Fusobacterium Nucleatum to Probiotics Populations, Based on Their Antagonistic Effect.

Review 6. Action and function of Faecalibacterium prausnitzii in health and disease.

Review 7. The role of intestinal bacteria in the development and progression of gastrointestinal tract neoplasms.

Review 8. The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy.

9. Association of Dietary Patterns With Risk of Colorectal Cancer Subtypes Classified by Fusobacterium nucleatum in Tumor Tissue.

10. Integration of pharmacology, molecular pathology, and population data science to support precision gastrointestinal oncology.

Review 1. The gut microbiome: what every gastroenterologist needs to know.

Review 2. Integration of microbiology, molecular pathology, and epidemiology: a new paradigm to explore the pathogenesis of microbiome-driven neoplasms.

Review 3. Oral microbiota and gastrointestinal cancer.

Review 4. Interplay between Dietary Polyphenols and Oral and Gut Microbiota in the Development of Colorectal Cancer.

Review 5. Influence of Iron on the Gut Microbiota in Colorectal Cancer.

6. Microbiome dysbiosis and alcoholic liver disease^☆.

Review 7. Mucosal lesions of the upper gastrointestinal tract in patients with ulcerative colitis: A review.

8. Apoptotic-Induced Effects of Acacia Catechu Willd. Extract in Human Colon Cancer Cells.

Review 9. Immune Dysfunctions and Immunotherapy in Colorectal Cancer: The Role of Dendritic Cells.

Review 10. Drug-Microbiota Interaction in Colon Cancer Therapy: Impact of Antibiotics.